Bill Text: NH HB1747 | 2018 | Regular Session | Introduced
Bill Title: Relative to packaging of certain controlled drugs.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2018-02-08 - Inexpedient to Legislate: Motion Adopted Voice Vote 02/08/2018 House Journal 3 P. 7 [HB1747 Detail]
Download: New_Hampshire-2018-HB1747-Introduced.html
HB 1747-FN - AS INTRODUCED
2018 SESSION
18-2400
01/04
HOUSE BILL 1747-FN
AN ACT relative to packaging of certain controlled drugs.
SPONSORS: Rep. Migliore, Graf. 9
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
This bill requires manufacturers to pre-package class II controlled drugs which are going to be dispensed in New Hampshire in blister packs with serial numbers on each pill.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
18-2400
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Eighteen
AN ACT relative to packaging of certain controlled drugs.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Packaging of Class II Controlled Drugs. Amend RSA 318-B by inserting after section 9 the following new section:
318-B:9-a Packaging of Class II Controlled Drugs. Manufacturers packaging class II controlled drugs to be dispensed in New Hampshire shall pre-package such drugs in individual dose blister packs with traceable inventory serial numbers on each pill.
2 Effective Date. This act shall take effect January 1, 2019.
18-2400
11/17/17
HB 1747-FN- FISCAL NOTE
AS INTRODUCED
AN ACT relative to packaging of certain controlled drugs.
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
|
| |||
| Estimated Increase / (Decrease) | |||
STATE: | FY 2019 | FY 2020 | FY 2021 | FY 2022 |
Appropriation | $0 | $0 | $0 | $0 |
Revenue | Indeterminable Increase | Indeterminable Increase | Indeterminable Increase | Indeterminable Increase |
Expenditures | Indeterminable Increase | Indeterminable Increase | Indeterminable Increase | Indeterminable Increase |
Funding Source: | [ X ] General [ ] Education [ ] Highway [ X ] Other - Federal Medicaid Revenue | |||
|
|
|
|
|
METHODOLOGY:
The Department of Health and Human Services assumes implementation of the packaging and tracking requirements in New Hampshire could cause some manufacturers to cease distributing class II drugs in New Hampshire or increase their prices to cover the additional packaging, tracking and distribution costs. The increase in costs to the Medicaid program for class II controlled drugs cannot be determined. Medicaid expenditures are paid with a combination of state and federal funds, therefore any increase in Medicaid expenditures will also increase federal restricted revenue by 50% of the expenditure increase.
The Office of Professional Licensure and Certification states this bill would have no fiscal impact on the Office or on the Board of Pharmacy.
AGENCIES CONTACTED:
Department of Health and Human Services and Office of Professional Licensure and Certification
